Melissa DePaoli Johnson | Scholars@Duke

Melissa DePaoli Johnson
Associate Professor in Medicine

Prognostic indicators for patients with Candida spp. bloodstream infections
Antifungal pharmacokinetics/pharmacodynamics
Immunogenetics among patients with candidiasis
Management of the HIV infected patient and antiretroviral pharmacotherapy
Antibacterial drug utilization, resistance, and appropriate prescribing

Current Appointments & Affiliations

Associate Professor in Medicine, Medicine, Infectious Diseases, Medicine 2013

Contact Information

Duke Box 102359, Durham, NC 27710
Room 173 Hanes House, 315 Trent Drive, Durham, NC 27710
johns200@mc.duke.edu (919) 684-2374

Background
Education, Training, & Certifications
- Pharm.D., Campbell University 1997
Duke Appointment History
- Assistant Professor in Medicine, Medicine, Infectious Diseases, Medicine 2007 - 2013
- Medical Instructor in the Department of Medicine, Medicine, Infectious Diseases, Medicine 2002 - 2007
Research
Selected Grants
- Improving antibiotic use through implementation and evaluation of Core Elements of Hospital Antibiotic Stewardship Programs (Domain 2) awarded by Centers for Disease Control and Prevention 2016 - 2019
- Effectiveness of Posaconazole Prophylaxis in Patients with Hematological Malignancies awarded by Merck Sharp & Dohme 2017 - 2019
- HIV Nurse Practitioner Training Program awarded by Health Resources and Service Administration 2013 - 2018
- Accelerating hospital reporting to NHSN's Antibiotic Use Option awarded by Centers for Disease Control and Prevention 2015 - 2017
- Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development awarded by National Institutes of Health 2014 - 2015
- Microfluidic PCR Platform to Detect Microbial DNA awarded by National Institutes of Health 2005 - 2010
- Host-Response relationships in patients with candidemia awarded by National Institutes of Health 2002 - 2008
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Mourad, Ahmad, Jonathan A. Stiber, John R. Perfect, and Melissa D. Johnson. “Real-world implications of QT prolongation in patients receiving voriconazole and amiodarone..” The Journal of Antimicrobial Chemotherapy 74, no. 1 (January 2019): 228–33. https://doi.org/10.1093/jac/dky392.
    Full Text
  - Kluyts, H. -. L., Y. le Manach, D. M. Munlemvo, F. Madzimbamuto, A. Basenero, Y. Coulibaly, S. Rakotoarison, et al. “The ASOS Surgical Risk Calculator: development and validation of a tool for identifying African surgical patients at risk of severe postoperative complications..” British Journal of Anaesthesia 121, no. 6 (December 2018): 1357–63. https://doi.org/10.1016/j.bja.2018.08.005.
    Full Text
  - Hostler, Christopher J., Rebekah W. Moehring, Elizabeth S Dodds Ashley, Melissa Johnson, Angelina Davis, Sarah S. Lewis, Daniel J. Sexton, Deverick J. Anderson, and Deverick J. CDC Prevention Epicenters Program. “Feasibility and Value of Developing a Regional Antibiogram for Community Hospitals..” Infect Control Hosp Epidemiol 39, no. 6 (June 2018): 718–22. https://doi.org/10.1017/ice.2018.71.
    Full Text Link to Item
  - Collar, Amanda L., Muthulekha Swamydas, Morgan O’Hayre, Md Sanaullah Sajib, Kevin W. Hoffman, Satya P. Singh, Ahmad Mourad, et al. “The homozygous CX3CR1-M280 mutation impairs human monocyte survival..” Jci Insight 3, no. 3 (February 8, 2018). https://doi.org/10.1172/jci.insight.95417.
    Full Text
  - Parente, V., R. H. Clark, L. Ku, C. Fennell, M. Johnson, E. Morris, A. Romaine, et al. “Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing..” J Perinatol 37, no. 2 (February 2017): 157–61. https://doi.org/10.1038/jp.2016.201.
    Full Text Link to Item
  - Matzaraki, Vasiliki, Mark S. Gresnigt, Martin Jaeger, Isis Ricaño-Ponce, Melissa D. Johnson, Marije Oosting, Lude Franke, et al. “An integrative genomics approach identifies novel pathways that influence candidaemia susceptibility..” Plos One 12, no. 7 (January 2017). https://doi.org/10.1371/journal.pone.0180824.
    Full Text
  - Roth, Susanne, Hanna Bergmann, Martin Jaeger, Assa Yeroslaviz, Konstantin Neumann, Paul-Albert Koenig, Clarissa Prazeres da Costa, et al. “Vav Proteins Are Key Regulators of Card9 Signaling for Innate Antifungal Immunity..” Cell Rep 17, no. 10 (December 6, 2016): 2572–83. https://doi.org/10.1016/j.celrep.2016.11.018.
    Full Text Link to Item
  - Cournoyer, Justin M., Aven P. Garms, Kimberly N. Thiessen, Margaret T. Bowers, Melissa D. Johnson, and Michael V. Relf. “Cardiovascular Disease and HIV: Pathophysiology, Treatment Considerations, and Nursing Implications..” Critical Care Nurse 36, no. 5 (October 2016): 37–46. https://doi.org/10.4037/ccn2016839.
    Full Text
  - Schneeweiss, Sebastian, Peggy L. Carver, Kausik Datta, Alicia Galar, Melissa D. Johnson, Matthew G. Johnson, Francisco M. Marty, et al. “Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study..” The Journal of Antimicrobial Chemotherapy 71, no. 10 (October 2016): 2938–44. https://doi.org/10.1093/jac/dkw225.
    Full Text
  - Maskarinec, Stacey A., Melissa D. Johnson, and John R. Perfect. “Genetic Susceptibility to Fungal Infections: What is in the Genes?.” Current Clinical Microbiology Reports 3, no. 2 (June 2016): 81–91. https://doi.org/10.1007/s40588-016-0037-3.
    Full Text
  - Swamydas, Muthulekha, Ji-Liang Gao, Timothy J. Break, Melissa D. Johnson, Martin Jaeger, Carlos A. Rodriguez, Jean K. Lim, et al. “CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival..” Science Translational Medicine 8, no. 322 (January 2016). https://doi.org/10.1126/scitranslmed.aac7718.
    Full Text
  - Jaeger, Martin, Robin van der Lee, Shih-Chin Cheng, Melissa D. Johnson, Vinod Kumar, Aylwin Ng, Theo S. Plantinga, et al. “The RIG-I-like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infections..” European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 34, no. 5 (May 2015): 963–74. https://doi.org/10.1007/s10096-014-2309-2.
    Full Text
  - American College of Clinical Pharmacy, Scot, Sarah E. McBane, Anna L. Dopp, Andrew Abe, Sandra Benavides, Elizabeth A. Chester, Dave L. Dixon, et al. “Collaborative drug therapy management and comprehensive medication management-2015..” Pharmacotherapy 35, no. 4 (April 2015): e39–50. https://doi.org/10.1002/phar.1563.
    Full Text Link to Item
  - Arnold, Christopher J., Melissa Johnson, Arnold S. Bayer, Suzanne Bradley, Efthymia Giannitsioti, José M. Miró, Pilar Tornos, et al. “Candida infective endocarditis: an observational cohort study with a focus on therapy..” Antimicrobial Agents and Chemotherapy 59, no. 4 (April 2015): 2365–73. https://doi.org/10.1128/AAC.04867-14.
    Full Text
  - Davies, Marie L., Melissa D. Johnson, Jamie N. Brown, William E. Bryan, and Mary L. Townsend. “Predictors of glycaemic control among HIV-positive veterans with diabetes.” International Journal of Std & Aids 26, no. 4 (March 2015): 262–67. https://doi.org/10.1177/0956462414535207.
    Full Text Link to Item
  - Ten Oever, Jaap, Matthijs Kox, Frank L. van de Veerdonk, Khutso M. Mothapo, Adriana Slavcovici, Tim L. Jansen, Lieke Tweehuysen, et al. “The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases..” Bmc Immunology 15 (November 19, 2014). https://doi.org/10.1186/s12865-014-0055-y.
    Full Text
  - Kumar, Vinod, Shih-Chin Cheng, Melissa D. Johnson, Sanne P. Smeekens, Agnieszka Wojtowicz, Evangelos Giamarellos-Bourboulis, Juha Karjalainen, et al. “Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia..” Nature Communications 5 (September 8, 2014). https://doi.org/10.1038/ncomms5675.
    Full Text
  - Paul DiMondi, V., Mary L. Townsend, Melissa Johnson, and Michael Durkin. “Antifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysis..” Pharmacotherapy 34, no. 7 (July 2014): e120–27. https://doi.org/10.1002/phar.1433.
    Full Text
  - Kung, Hsiang-Chi, Melissa D. Johnson, Richard H. Drew, Paramita Saha-Chaudhuri, and John R. Perfect. “Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study..” Cancer Medicine 3, no. 3 (June 2014): 667–73. https://doi.org/10.1002/cam4.225.
    Full Text Open Access Copy
  - Rosentul, Diana C., Theo S. Plantinga, Marius Farcas, Marije Oosting, Omar J. M. Hamza, William K. Scott, Barbara D. Alexander, et al. “Role of autophagy genetic variants for the risk of Candida infections..” Medical Mycology 52, no. 4 (May 2014): 333–41. https://doi.org/10.1093/mmy/myt035.
    Full Text
  - Smeekens, S. P., R. K. Malireddi, T. S. Plantinga, K. Buffen, M. Oosting, L. A. B. Joosten, B. J. Kullberg, et al. “Autophagy is redundant for the host defense against systemic Candida albicans infections..” European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 33, no. 5 (May 2014): 711–22. https://doi.org/10.1007/s10096-013-2002-x.
    Full Text
  - Alexander, B. D., M. D. Johnson, C. D. Pfeiffer, C. Jiménez-Ortigosa, J. Catania, and R. Booker. “Erratum: Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations (Clinical Infectious Diseases (2013) 56 (1724-32)).” Clinical Infectious Diseases 58, no. 5 (March 1, 2014). https://doi.org/10.1093/cid/cit956.
    Full Text
  - Smeekens, S. P., R. K. Malireddi, T. S. Plantinga, K. Buffen, M. Oosting, L. A. B. Joosten, B. J. Kullberg, et al. “Autophagy is redundant for the host defense against systemic Candida albicans infections.” European Journal of Clinical Microbiology and Infectious Diseases 33, no. 5 (January 1, 2014): 711–22. https://doi.org/10.1007/s10096-013-2002-x.
    Full Text
  - Lionakis, Michail S., Muthulekha Swamydas, Brett G. Fischer, Theo S. Plantinga, Melissa D. Johnson, Martin Jaeger, Nathaniel M. Green, et al. “CX3CR1-dependent renal macrophage survival promotes Candida control and host survival..” J Clin Invest 123, no. 12 (December 2013): 5035–51. https://doi.org/10.1172/JCI71307.
    Full Text Link to Item
  - Oever, J. ten, E. J. Giamarellos-Bourboulis, F. L. van de Veerdonk, F. F. Stelma, A. Simon, M. Janssen, M. Johnson, et al. “Circulating galectin-3 in infections and non-infectious inflammatory diseases..” European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 32, no. 12 (December 2013): 1605–10. https://doi.org/10.1007/s10096-013-1919-4.
    Full Text
  - Alexander, Barbara D., Melissa D. Johnson, Christopher D. Pfeiffer, Cristina Jiménez-Ortigosa, Jelena Catania, Rachel Booker, Mariana Castanheira, Shawn A. Messer, David S. Perlin, and Michael A. Pfaller. “Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations..” Clin Infect Dis 56, no. 12 (June 2013): 1724–32. https://doi.org/10.1093/cid/cit136.
    Full Text Link to Item
  - DeFreitas, Ashley A., Theresa-Lynda M. D’Souza, Ginille J. Lazaro, Emily M. Windes, Melissa D. Johnson, and Michael V. Relf. “Pharmacological considerations in human immunodeficiency virus-infected adults in the intensive care unit..” Critical Care Nurse 33, no. 2 (April 2013): 46–56. https://doi.org/10.4037/ccn2013854.
    Full Text
  - Oever, J. T., E. J. Giamarellos-Bourboulis, F. L. V. D. Veerdonk, F. F. Stelma, A. Simon, M. Janssen, M. Johnson, et al. “Circulating galectin-3 in infections and non-infectious inflammatory diseases.” European Journal of Clinical Microbiology and Infectious Diseases 32, no. 12 (2013): 1605–10. https://doi.org/10.1007/s10096-013-1919-4.
    Full Text
  - Smeekens, Sanne P., Aylwin Ng, Vinod Kumar, Melissa D. Johnson, Theo S. Plantinga, Cleo van Diemen, Peer Arts, et al. “Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans..” Nature Communications 4 (January 2013). https://doi.org/10.1038/ncomms2343.
    Full Text
  - Plantinga, Theo S., Melissa D. Johnson, William K. Scott, Leo A. B. Joosten, Jos W. M. van der Meer, John R. Perfect, Bart Jan Kullberg, and Mihai G. Netea. “Human genetic susceptibility to Candida infections..” Medical Mycology 50, no. 8 (November 2012): 785–94. https://doi.org/10.3109/13693786.2012.690902.
    Full Text
  - Dodds Ashley, Elizabeth, Richard Drew, Melissa Johnson, Robert Danna, Dominika Dabrowski, Valery Walker, Manishi Prasad, Barbara Alexander, George Papadopoulos, and John Perfect. “Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options..” Pharmacotherapy 32, no. 10 (October 2012): 890–901. https://doi.org/10.1002/j.1875-9114.2012.01124.
    Full Text
  - Ashley, ED, Drew, R, Johnson, M, Danna, R, Dabrowski, D, Walker, V, Prasad, M, Alexander, B, Papadopoulos, G, and Perfect, J. "Cost of Invasive Fungal Infections in the Era of New Diagnostics and Expanded Treatment Options." Pharmacotherapy (September 18, 2012). Full Text Link to Item
  - Schell, W. A., J. L. Benton, P. B. Smith, M. Poore, J. L. Rouse, D. J. Boles, M. D. Johnson, et al. “Evaluation of a digital microfluidic real-time PCR platform to detect DNA of Candida albicans in blood..” European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 31, no. 9 (September 2012): 2237–45. https://doi.org/10.1007/s10096-012-1561-6.
    Full Text Open Access Copy
  - Plantinga, Theo S., Melissa D. Johnson, William K. Scott, Esther van de Vosse, Digna R. Velez Edwards, P Brian Smith, Barbara D. Alexander, et al. “Toll-like receptor 1 polymorphisms increase susceptibility to candidemia..” The Journal of Infectious Diseases 205, no. 6 (March 2012): 934–43. https://doi.org/10.1093/infdis/jir867.
    Full Text
  - Rosentul, D. C., T. S. Plantinga, W. K. Scott, B. D. Alexander, N. M. D. van de Geer, J. R. Perfect, B. J. Kullberg, M. D. Johnson, and M. G. Netea. “The impact of caspase-12 on susceptibility to candidemia..” European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 31, no. 3 (March 2012): 277–80. https://doi.org/10.1007/s10096-011-1307-x.
    Full Text
  - Johnson, Melissa D., Theo S. Plantinga, Esther van de Vosse, Digna R. Velez Edwards, P Brian Smith, Barbara D. Alexander, John C. Yang, et al. “Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study..” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 54, no. 4 (February 2012): 502–10. https://doi.org/10.1093/cid/cir827.
    Full Text
  - Rosentul, Diana C., Theo S. Plantinga, Marije Oosting, William K. Scott, Digna R. Velez Edwards, P Brian Smith, Barbara D. Alexander, et al. “Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia..” The Journal of Infectious Diseases 204, no. 7 (October 2011): 1138–45. https://doi.org/10.1093/infdis/jir458.
    Full Text
  - Ashley, E. D., and M. D. Johnson. “Combination antifungal therapy,” January 1, 2011, 153–63. https://doi.org/10.1007/978-1-4419-6640-7_10.
    Full Text
  - Goswami, Neela D., Melissa D. Johnson, and Vivian H. Chu. “Ertapenem for treatment of osteomyelitis: a case series..” Bmc Research Notes 4 (January 2011). https://doi.org/10.1186/1756-0500-4-478.
    Full Text
  - Johnson, M. D., and M. Netea. “Host Genomics and Bacterial Infections,” December 1, 2010, 744–59. https://doi.org/10.1016/B978-0-12-374934-5.00058-1.
    Full Text
  - Johnson, Melissa D., and John R. Perfect. “Use of Antifungal Combination Therapy: Agents, Order, and Timing..” Current Fungal Infection Reports 4, no. 2 (May 2010): 87–95. https://doi.org/10.1007/s12281-010-0018-6.
    Full Text
  - Heil, Emily L., Mary L. Townsend, Kenneth Shipp, Amy Clarke, and Melissa D. Johnson. “Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients..” Aids Research and Treatment 2010 (January 2010). https://doi.org/10.1155/2010/856542.
    Full Text
  - Johnson, M. D., and M. Netea. “Host Genomics and Bacterial Infections,” December 1, 2009, 1347–61. https://doi.org/10.1016/B978-0-12-369420-1.00110-4.
    Full Text
  - Ferwerda, Bart, Gerben Ferwerda, Theo S. Plantinga, Janet A. Willment, Annemiek B. van Spriel, Hanka Venselaar, Clara C. Elbers, et al. “Human dectin-1 deficiency and mucocutaneous fungal infections..” The New England Journal of Medicine 361, no. 18 (October 2009): 1760–67. https://doi.org/10.1056/NEJMoa0901053.
    Full Text
  - Johnson, M. D. “Pharmacogenomics of systemic antifungal agents.” Current Fungal Infection Reports 3, no. 2 (June 1, 2009): 111–16. https://doi.org/10.1007/s12281-009-0015-9.
    Full Text
  - Connelly, Sarah M., Jane V. Trinh, Melissa D. Johnson, Elizabeth S. Dodds-Ashley, Jason Stout, John J. Engemann, N Deborah Friedman, Donald Kaye, and Keith S. Kaye. “Mortality and time to extubation in severe hospital-acquired pneumonia..” American Journal of Infection Control 37, no. 2 (March 2009): 143–49. https://doi.org/10.1016/j.ajic.2008.03.011.
    Full Text
  - Mohr, John, Melissa Johnson, Travis Cooper, James S. Lewis, and Luis Ostrosky-Zeichner. “Current options in antifungal pharmacotherapy..” Pharmacotherapy 28, no. 5 (May 2008): 614–45. https://doi.org/10.1592/phco.28.5.614.
    Full Text
  - Bentley, D., and M. Johnson. “Safety in healthcare is not a new concept.” International Surgery 93, no. 3 (2008): 139–40.
  - Lalani, Tahaniyat, Jay B. Varkey, Richard Drew, Lizzie Harrell, Sarah McGarry, John G. Engemann, Melissa D. Johnson, and Keith S. Kaye. “Analysis of two- and three-year trends in antimicrobial resistance in intensive care units using unit-specific antibiograms..” Scandinavian Journal of Infectious Diseases 40, no. 8 (January 2008): 672–74. https://doi.org/10.1080/00365540801971403.
    Full Text
  - Townsend, Mary L., Stephanie B. Hollowell, Jasmin Bhalodia, Kenneth H. Wilson, Keith S. Kaye, and Melissa D. Johnson. “A comparison of the effectiveness of lipid-lowering therapy between HIV- and non-HIV-infected subjects with hyperlipidaemia..” International Journal of Std & Aids 18, no. 12 (December 2007): 851–55. https://doi.org/10.1258/095646207782716974.
    Full Text
  - Johnson, M. D., and J. R. Perfect. “Combination antifungal therapy: what can and should we expect?.” Bone Marrow Transplantation 40, no. 4 (August 2007): 297–306. https://doi.org/10.1038/sj.bmt.1705687.
    Full Text
  - Smith, P Brian, Daniel K. Benjamin, Barbara D. Alexander, Melissa D. Johnson, Malcolm A. Finkelman, and William J. Steinbach. “Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting..” Clin Vaccine Immunol 14, no. 7 (July 2007): 924–25. https://doi.org/10.1128/CVI.00025-07.
    Full Text Link to Item
  - Zaas, Aimee K., Elizabeth S. Dodds Ashley, Barbara D. Alexander, Melissa D. Johnson, and John R. Perfect. “Caspofungin for invasive candidiasis at a tertiary care medical center..” The American Journal of Medicine 119, no. 11 (November 2006): 993.e1-993.e6. https://doi.org/10.1016/j.amjmed.2006.02.029.
    Full Text
  - Anaissie, Elias J., Brahm H. Segal, John R. Graybill, Carola Arndt, John R. Perfect, Michael Kleinberg, Peter Pappas, et al. “Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt..” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 43, no. 8 (October 2006): 1031–39. https://doi.org/10.1086/509116.
    Full Text
  - Johnson, Melissa D., Michael Kleinberg, Larry Danziger, and Luis Ostrosky-Zeichner. “Pharmacoeconomics of antifungal pharmacotherapy--challenges and future directions..” Expert Opinion on Pharmacotherapy 6, no. 15 (December 2005): 2617–32. https://doi.org/10.1517/14656566.6.15.2617.
    Full Text
  - Pope, Scott D., Melissa D. Johnson, and D Byron May. “Pharmacotherapy for human immunodeficiency virus-associated nephropathy..” Pharmacotherapy 25, no. 12 (December 2005): 1761–72. https://doi.org/10.1592/phco.2005.25.12.1761.
    Full Text
  - Johnson, Melissa D., Conan MacDougall, Luis Ostrosky-Zeichner, John R. Perfect, and John H. Rex. “Combination antifungal therapy..” Antimicrobial Agents and Chemotherapy 48, no. 3 (March 2004): 693–715. https://doi.org/10.1128/AAC.48.3.693-715.2004.
    Full Text
  - Johnson, Melissa D., and John R. Perfect. “Caspofungin: first approved agent in a new class of antifungals..” Expert Opinion on Pharmacotherapy 4, no. 5 (May 2003): 807–23. https://doi.org/10.1517/14656566.4.5.807.
    Full Text
  - Johnson, Melissa D., Carol D. Hamilton, Richard H. Drew, Linda L. Sanders, Gennethel J. Pennick, and John R. Perfect. “A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution..” The Journal of Antimicrobial Chemotherapy 51, no. 2 (February 2003): 453–57. https://doi.org/10.1093/jac/dkg089.
    Full Text
  - Bohjanen, Paul R., Melissa D. Johnson, Lynda A. Szczech, Dannah W. Wray, William P. Petros, Cameron R. Miller, and Charles B. Hicks. “Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis..” Antimicrobial Agents and Chemotherapy 46, no. 8 (August 2002): 2387–92. https://doi.org/10.1128/AAC.46.8.2387-2392.2002.
    Full Text
  - Johnson, Melissa D., and John R. Perfect. “Fungal Infections of the Bones and Joints..” Current Infectious Disease Reports 3, no. 5 (October 2001): 450–60. https://doi.org/10.1007/s11908-007-1002-3.
    Full Text
  - Johnson, M. D., R. H. Drew, and J. R. Perfect. “Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literature..” Pharmacotherapy 18, no. 5 (September 1998): 1053–61.
- Book Sections
  - Drew, R. H., M. D. Johnson, E. D. Ashley, and J. R. Perfect. “Rational use of antifungals for invasive fungal infections in the institutional setting.” In Antibiotic Optimization: Concepts and Strategies in Clinical Practice, 577–644, 2004.
- Conference Papers
  - Davies, Marie L., Melissa D. Johnson, Jamie N. Brown, William E. Bryan, and Mary L. Townsend. “Predictors of glycaemic control among HIV-positive veterans with diabetes..” In International Journal of Std & Aids, 26:262–67, 2015. https://doi.org/10.1177/0956462414535207.
    Full Text
  - Depner, M., F. van de Veerdonk, J. Wanders, H. Stauss, J. Raabe, T. P. Atkinson, H. W. Schroeder, et al. “MUTATION SCREENING IN STAT1, CARD9 AND PKC-DELTA IN PATIENTS WITH CHRONIC MUCOCUTANEOUS CANDIDIASIS.” In Journal of Clinical Immunology, 32:334–35. SPRINGER/PLENUM PUBLISHERS, 2012.
    Link to Item
Teaching & Mentoring
Recent Courses
- NURSING 841: Pharmacologic Aspects of HIV/AIDS 2019

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Selected Grants

Selected Publications

Academic Articles

Book Sections

Conference Papers

Recent Courses